| related words |
| refusal |
| oncotype |
| convenient |
| disciplinary |
| profession |
| undergoes |
| approving |
| luxembourg |
| devoting |
| unacceptable |
| tort |
| kalbitor |
| literature |
| mg |
| detecting |
| cache |
| eventual |
| unallocated |
| labeling |
| dosage |
|
| related documents |
| 1254419--3/1/2010--MEDASSETS_INC |
| 1173394--3/31/2009--GOLDMAN_SACHS_HEDGE_FUND_PARTNERS_LLC |
| 1097149--2/27/2009--ALIGN_TECHNOLOGY_INC |
| 881464--2/26/2010--AMYLIN_PHARMACEUTICALS_INC |
| 1212235--3/17/2008--XTENT_INC |
| 1036968--3/18/2008--VAXGEN_INC |
| 1056358--3/12/2009--MANNATECH_INC |
| 831547--3/14/2008--SPECTRUM_PHARMACEUTICALS_INC |
| 1254419--3/24/2008--MEDASSETS_INC |
| 1106935--3/16/2010--IVANHOE_ENERGY_INC |
| 1173394--3/31/2008--GOLDMAN_SACHS_HEDGE_FUND_PARTNERS_LLC |
| 1193558--2/28/2008--AMERICAN_FINANCIAL_REALTY_TRUST |
| 1342960--3/29/2007--DIVX_INC |
| 1036968--8/30/2007--VAXGEN_INC |
| 1036968--5/31/2007--VAXGEN_INC |
| 881464--2/26/2007--AMYLIN_PHARMACEUTICALS_INC |
| 1036968--2/7/2007--VAXGEN_INC |
| 1097149--2/26/2008--ALIGN_TECHNOLOGY_INC |
| 1173394--3/30/2010--GOLDMAN_SACHS_HEDGE_FUND_PARTNERS_LLC |
| 72444--3/10/2010--NABI__BIOPHARMACEUTICALS |
|
| related topics |
| {regulation, change, law} |
| {product, liability, claim} |
| {product, candidate, development} |
| {regulation, government, change} |
| {interest, director, officer} |
| {debt, indebtedness, cash} |
| {operation, international, foreign} |
| {provision, law, control} |
| {condition, economic, financial} |
| {tax, income, asset} |
| {cost, operation, labor} |
| {competitive, industry, competition} |
| {capital, credit, financial} |
| {property, intellectual, protect} |
| {acquisition, growth, future} |
| {investment, property, distribution} |
| {cost, regulation, environmental} |
| {financial, litigation, operation} |
| {stock, price, operating} |
| {control, financial, internal} |
|